Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Products are for qualified researchers in academic, pharmaceutical or biotechnology settings with appropriate training and facilities
Retatrutide is a synthetic peptide based on a glucose-dependent insulinotropic polypeptide (GIP) backbone, but uniquely, it functions as a triple agonist
It is not approved by any regulatory authority and has not been evaluated for safety or efficacy in humans
You know exactly what's in the vial
It lifts the brain fog and reduces the neurological inflammation associated with autoimmune flare-ups
Safety Profile and Possible Side Effects Preclinical studies show BPC-157 was well-tolerated with no serious toxicity in mice, rats, rabbits, and dogs
/assets/images/provider/photos/2775923.jpeg)
